Thomas D Schiano, MD
- PROFESSOR | Medicine, Liver Diseases
Specialties:Liver Transplantation, Liver Medicine, Intestinal Transplantation
Dr. Thomas D. Schiano has a clinical background in hepatology, gastroenterology and clinical nutrition. He has expertise in the management of patients with cirrhosis and other acute/chronic liver diseases, as well as caring for patients prior to and after liver and intestinal transplantation. Dr. Schiano has varied clinical research interests including herbal treatments of liver disease, nutritional aspects of liver disease, recurrence of disease post liver transplantation, living donor liver transplantation, and management of the complications of cirrhosis. In addition, he is member of the liver thrombosis program - an international referral center for adults and children with difficult to diagnose and unique blood clotting disorders affecting the liver and intestines.
Dr. Schiano is a professor of medicine, a UNOS-certified Liver Transplant physician, and is board certified in internal medicine, clinical nutrition, and gastroenterology.
Dr. Schiano is Medical Director of Adult Liver Transplantation and Director of Clinical Hepatology and Intestinal Transplantation at the Recanati/Miller Transplantation Institute.
RMTI website: www.mountsinaiRMTI.org
- Alcohol Abuse And Alcoholism
- Endoscopic Band Ligation
- Hepatitis A
- Hepatitis B
MD, Universidad Del Noreste
Residency, Internal Medicine, Maimonides Medical Center
Fellowship, Clinical Nutrition, Memorial Sloan-Kettering
Fellowship, Gastroenterology, Temple University Hospital
Fellowship, Liver Disease-Trans, Mount Sinai Hospital
2012 American Liver Foundation Physician of the Year
Castle-Connolly America's Top Doctors
Manhattan Chapter Triangle Award
Sol Sherry Award
Award for Excellence
Award for Excellence
Award for Excellence
Liver transplantation, living donor liver transplantation, herbal and drug hepatotoxicity, nutrition, cirrhosis, intestinal transplantation, recurrence of disease post-liver transplantation, treatment of viral hepatitis post-liver transplantation, herbal and alternative treatments of chronic liver disease, complications of cirrhosis, portal hypertension, cholestasis associated with TPN.
Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, Ragni MV, Barin B, Simon D, Olthoff KM, Johnson L, Stosor V, Jayaweera D, Fung J, Sherman KE, Subramanian A, Millis JM, Slakey D, Berg CL, Carlson L, Ferrell L, Stablein DM, Odim J, Fox L, Stock PG. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2012 Jun; 18(6).
Fiel MI, Schiano TD. Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation. Current opinion in organ transplantation 2012 Jun; 17(3).
Levitsky J, Fiel MI, Norvell JP, Wang E, Watt KD, Curry MP, Tewani S, McCashland TM, Hoteit MA, Shaked A, Saab S, Chi AC, Tien A, Schiano TD. Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology 2012 May; 142(5).
Fiel MI, Deniz K, Elmali F, Schiano TD. Increasing hepatic arteriole wall thickness and decreased luminal diameter occur with increasing age in normal livers. Journal of hepatology 2011 Sep; 55(3).
Stanca CM, Montazem AH, Lawal A, Zhang JX, Schiano TD, Branch AD, Nelson C, Bodenheimer H, Thung S, Chung RT, Schwartz ME, Cheng B. Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2010 Jan; 68(1).
Fiel MI, Sauter B, Wu HS, Rodriguez-Laiz G, Gondolesi G, Iyer K, Schiano TD, Dagan S, Graham N, Williams PV, Tur-Kaspa R. Regression of hepatic fibrosis after intestinal transplantation in total parenteral nutrition liver disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008 Aug; 6(8).
Schiano TD, Charlton M, Younossi Z, Galun E, Pruett T, Andrews J, Eren R, Dagan S, Graham N, Williams PV, Tur-Kaspa R. Monoclonal antibody HCV-AbxTL68 in patients undergoing liver transplantation for HCV: Results of a Phase 2 randomized study. Liver Transpl 2006; 12: 1381-1389.
Poonawala Khapra A, Agarwal K, Fiel MI, Schiano TD, Hossain S, Emre S, Kontorinis N. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using hepatitis C+ allografts. Liver Transpl 2006; 12: 1496-1503.
Carmiel-Haggai M, Fiel MI, Gaddipati HC, Abittan C, Schiano TD, Roayaie S, Emre S, Gondolesi G, Schwartz M, Hossain S. Frequency of hepatitis C recurrence and factors affecting patient outcome after re-transplantation for recurrent hepatitis C. Liver Transpl 2005; 11: 1567-1573.
Schiano TD, Gutierrez JA, Walewski JL, Fiel MI, Fernandez EJ, Branch AD, Nelson C, Bodenheimer H, Thung S, Chung RT, Schwartz ME, Cheng B. HCV levels rise quickly in liver transplant patients with live donors, persistent ALT elevations often follow. Hepatology 2005; 42: 1420-1428.
Harpaz N, Schiano TD, Ruf AE, Sauter BV, Tao Y, Fishbein TM, Shukla D. Early and frequent histological re-currence of Crohn's disease in small intestinal allografts. Transplantation 2005; 80: 1667-1670.